4
Changes in Ownership
RESMED INC Filed Acc 0001127602-24-025433
Chief Commercial Officer, SaaS sold 4,260 shares at $238.48 ($1,015,925)
- Chief Commercial Officer, SaaS acquired 4,260 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ghoshal Kaushik · Chief Commercial Officer, SaaS
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,260 | $101.64 | $432,986 | 26,048 | D |
| 2024-10-11 | Sale : show line 2 in the form 10b5-1 | −4,260 | $238.48 | $1,015,925 | 21,788 | D |
| Open-market sales · 4,260 sh · avg $238.48 · $1,015,925 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-11 | Exercise or conversion : show line 3 in the form 10b5-1 ResMed Common Stock Options | −4,260 | 0 | D |
Loading xslF345X05/form4.xml…